Patents by Inventor Elliott Kagan

Elliott Kagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • siRNA SILENCING OF FILOVIRUS GENE EXPRESSION
    Publication number: 20110177131
    Abstract: The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.
    Type: Application
    Filed: September 9, 2010
    Publication date: July 21, 2011
    Applicant: Protiva Biotherapeutics, Inc.
    Inventors: Ian MacLachlan, Vandana Sood, Thomas W. Geisbert, Lisa E. Hensley, Elliott Kagan
  • siRNA silencing of filovirus gene expression
    Patent number: 7838658
    Abstract: The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: November 23, 2010
    Inventors: Ian MacLachlan, Vandana Sood, Thomas W. Geisbert, Lisa E. Hensley, Elliott Kagan
  • siRNA silencing of filovirus gene expression
    Publication number: 20070135370
    Abstract: The present invention provides siRNA molecules that target Filovirus gene expression and methods of using such siRNA molecules to silence Filovirus gene expression. The present invention also provides nucleic acid-lipid particles that target Filovirus gene expression comprising an siRNA that silences Filovirus gene expression, a cationic lipid, and a non-cationic lipid.
    Type: Application
    Filed: October 20, 2006
    Publication date: June 14, 2007
    Applicant: Protiva Biotherapeutics, Inc.
    Inventors: Ian MacLachlan, Vandana Sood, Thomas Geisbert, Lisa Hensley, Elliott Kagan